Source: Clinical and Experimental Immunology. Conference titles: Meeting of The European Society for Immunodeficiency. Unidade: FM
Subjects: AGAMAGLOBULINEMIA, TRANSTORNOS LINFOPROLIFERATIVOS, FÁRMACOS IMUNOSSUPRESSORES, RESUMOS (EVENTOS)
ABNT
CARNEIRO-SAMPAIO, M. et al. Persistent hypogammaglobulinemia after rituximab therapy for post-transplant lymphoproliferative disease. Clinical and Experimental Immunology. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2008APA
Carneiro-Sampaio, M., Jacob, C. M. A., Odone Filho, V., Tannuri, U., Stefani, G. P., Higa, M., et al. (2008). Persistent hypogammaglobulinemia after rituximab therapy for post-transplant lymphoproliferative disease. Clinical and Experimental Immunology. London: Faculdade de Medicina, Universidade de São Paulo.NLM
Carneiro-Sampaio M, Jacob CMA, Odone Filho V, Tannuri U, Stefani GP, Higa M, Pastorino AC, Castro APBM, Fomin AB. Persistent hypogammaglobulinemia after rituximab therapy for post-transplant lymphoproliferative disease. Clinical and Experimental Immunology. 2008 ; 154 79.[citado 2024 nov. 03 ]Vancouver
Carneiro-Sampaio M, Jacob CMA, Odone Filho V, Tannuri U, Stefani GP, Higa M, Pastorino AC, Castro APBM, Fomin AB. Persistent hypogammaglobulinemia after rituximab therapy for post-transplant lymphoproliferative disease. Clinical and Experimental Immunology. 2008 ; 154 79.[citado 2024 nov. 03 ]